| 前收市價 | 0.8500 |
| 開市 | 0.8500 |
| 買盤 | 0.0000 |
| 賣出價 | 1.1000 |
| 拍板 | 2.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 0.8500 - 0.8500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 189 |
ZacksEsperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk
Esperion's (ESPR) Nilemdo & Nustendi get the European Commission's nod for label expansion based on data from the CLEAR Outcomes study.
ZacksEsperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Insider MonkeyEsperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript May 7, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17. ESPR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […]
